GINZA NOA CLINIC
Tokyo, Japan International Patient Support
Contact Us

Can Stem Cell Therapy Trigger Allergies?

Yes. Stem cell treatment can cause an allergic reaction, including anaphylaxis. Depending on the product, the trigger may be an ingredient such as DMSO, which protects frozen cells, or traces of animal-derived proteins used during cell preparation. The Ryoncil label specifically warns about these risks.DrugInfo.cfm?setid=a4e0918f 7444 4694 adeb d38d98345659 Using your own cells does not remove the need to check the ingredients and medicines used with them.

There is no single allergy percentage that applies to every stem cell treatment. Blood stem cell transplants in hospital involve different patients, products, and infusion volumes from outpatient cell injections; their complication rates cannot be used as your personal risk estimate.29891441 Ask about the exact product, your allergy history, and the team’s plan for a reaction.

Can Stem Cell Therapy Trigger Allergies?

One important distinction: Ryoncil is a donor bone marrow-derived mesenchymal stromal cell (MSC) product approved in the United States for steroid-refractory acute graft-versus-host disease in children aged 2 months and older. It was the first FDA-approved MSC therapy. Its approval does not validate other cell products or uses.Fda approves first mesenchymal stromal cell therapy treat steroid refractory acute graft versus host

Which symptoms need urgent help?

Watch for hives, itching, flushing, swelling of the lips or tongue, wheezing, throat tightness, vomiting, dizziness, or fainting. Anaphylaxis can begin quickly and become life-threatening; do not assume that symptoms must progress through a mild stage first.Anaphylaxis

During treatment, report new symptoms to the clinical team immediately. Trouble breathing, throat swelling, or collapse requires emergency help. If a prescribed epinephrine auto-injector is available, use it promptly as directed and call local emergency services. Do not wait for an online consultation.Anaphylaxis

Not every infusion reaction is an allergy. Fever, chills, nausea, and blood pressure changes can have several causes. However, the Ryoncil label also lists fever, breathing difficulty, and low blood pressure among possible hypersensitivity symptoms. Symptoms alone do not reliably identify the cause, so staff need to assess them rather than dismiss them as a routine side effect.DrugInfo.cfm?setid=a4e0918f 7444 4694 adeb d38d98345659

What can trigger a reaction?

The ingredient list matters more than broad claims such as “natural cells.” Ryoncil is contraindicated in people with known hypersensitivity to DMSO or porcine and bovine proteins. Its formulation also contains human serum albumin. Other cell products may have different ingredients; the same warnings cannot simply be copied across all treatments.DrugInfo.cfm?setid=a4e0918f 7444 4694 adeb d38d98345659

Potential exposure Why it matters What to check
DMSO A cryoprotectant in some frozen cell products; named in Ryoncil’s hypersensitivity warning Does this product contain DMSO, and does your documented allergy make it unsuitable?
Porcine or bovine proteins Trace proteins from manufacturing may remain in some products Which animal-derived reagents are used, and what does the product’s contraindication section say?
Human serum albumin or other formulation ingredients The carrier or stabilizer is part of the treatment exposure too Obtain the complete formulation and tell the clinician about any previous reaction to an ingredient.
Medicines and procedural materials Exposure is not limited to the cell product; medicines and latex can also cause allergic reactions Review the planned drugs and materials, including antibiotics, local anesthetics, latex, and any contrast agent.

Medication and latex reactions are recognized causes of anaphylaxis. If a reaction occurs around a procedure, the clinical team needs to consider all exposures, not automatically blame the cells.Anaphylaxis

Does washing make an unsuitable product safe?

Do not assume so. Ryoncil’s preparation instructions describe thawing the product and combining it with Plasma-Lyte; they do not provide a washing step to bypass its contraindications. Dilution is not the same as removing an allergen. A known DMSO or relevant animal-protein allergy remains a reason not to use Ryoncil.DrugInfo.cfm?setid=a4e0918f 7444 4694 adeb d38d98345659 For another product, ask the treating clinician about its authorized or study-specific preparation procedure rather than requesting an improvised change.

Are your own cells less likely to cause allergies?

“Autologous” means the cells come from your own body; “allogeneic” means they come from a donor. Using your own cells avoids donor mismatch, but it does not remove exposure to freezing agents, formulation ingredients, or drugs used during the procedure. Comparing autologous and allogeneic stem cells is therefore only part of an allergy assessment.

Donor-cell immune complications are not all allergies. In a blood stem cell transplant, graft-versus-host disease (GVHD) occurs when donor white blood cells attack the recipient’s tissues. That is different from an immediate allergic reaction to an infusion.Stem cell transplant GVHD after a blood transplant should not be treated as an allergy rate for a donor MSC injection.

How often do allergic reactions happen?

The available figures describe different outcomes. An infusion-reaction rate is not automatically an allergy rate, and neither is a rate of all life-threatening complications.

Evidence What was reported What it does not tell you
Ryoncil single-arm study: 54 treated children with steroid-refractory acute GVHD after donor transplantation; median age 7 Three stopped treatment because of acute infusion reactions. This is a patient-level count across treatment, not a per-infusion rate.DrugInfo.cfm?setid=a4e0918f 7444 4694 adeb d38d98345659 The label does not establish that all three were proven allergies. These children are not representative of routine outpatient cell-treatment patients.
Japanese prospective surveillance: 1,125 blood stem cell transplants, with events recorded within 24 hours Three transplants (0.3%) had life-threatening complications. One was anaphylaxis; the other two were hypoxia and kidney injury.29891441 The 0.3% is not an anaphylaxis rate and cannot be transferred to a different cell product or injection route.

In the Japanese study, high infusion volume was associated with grade 2 or worse allergic reactions in allogeneic transplant recipients, with an odds ratio of 7.54. A history of transfusion reactions was associated with adverse events overall, with an odds ratio of 1.46. These are associations in that transplant setting, not a prediction that your allergy probability is multiplied by those amounts.29891441

A separate meta-analysis included 62 randomized MSC trials with 3,546 participants across different diseases, using intravenous or local administration. Transient fever was more frequent with MSC treatment: odds ratio 3.65, with a 95% confidence interval of 2.05–6.49. The pooled analysis did not find a statistically significant increase in death or infection compared with controls. That does not mean no deaths or infections occurred, and fever is not itself proof of an allergy.34663461

The review’s follow-up periods varied, with the longest reported as five years. It does not provide a reliable estimate of new, persistent allergies after treatment. Nor can pooled trial findings establish the safety of a particular private clinic’s product. New or persistent symptoms after treatment need clinical assessment rather than an assumption that the cells did—or did not—cause them.34663461

What if you already have allergies?

A known allergy to a product ingredient is directly relevant to treatment selection. For Ryoncil, the specific contraindications are DMSO and porcine or bovine proteins; the label does not list ordinary hay fever as a contraindication. Hay fever alone is nevertheless not enough information to decide that another treatment is safe.DrugInfo.cfm?setid=a4e0918f 7444 4694 adeb d38d98345659

Bring the name of the suspected trigger, how soon symptoms began, what happened, and what treatment you needed. Include reactions to transfusions, medicines, contrast agents, latex, albumin, or previous cell products. If the cause of an earlier serious reaction is unclear, ask whether an allergy specialist should review it before treatment.

Use a written exposure check before booking

If your medical record documents a DMSO allergy and the proposed product is Ryoncil, compare the record with the label’s contraindications. Raise the conflict with the treating clinician rather than accept reassurance that the cells are natural or that washing will solve it.DrugInfo.cfm?setid=a4e0918f 7444 4694 adeb d38d98345659

For any proposed treatment, put three documents side by side: your reaction history, the complete product and procedure ingredient list, and the clinic’s written monitoring and emergency arrangements. Mark missing ingredients or unclear answers for the clinician to resolve. Do not try a small dose or stop prescribed medicines on your own to test whether you will react.

How should the team reduce and manage risk?

Premedication does not make a contraindicated product suitable or guarantee that anaphylaxis cannot happen. Ryoncil’s label calls for corticosteroids and antihistamines 30 to 60 minutes before administration, close monitoring, and interruption of the infusion if a reaction occurs. It says not to administer Ryoncil to patients who experience serious or life-threatening reactions.DrugInfo.cfm?setid=a4e0918f 7444 4694 adeb d38d98345659

Before agreeing to treatment, ask for written answers to these questions:

  1. What is the exact product, cell source, administration route, and complete ingredient list?
  2. Which of my previous reactions or diagnosed allergies would rule this product out?
  3. What preparation method, infusion volume, and rate does the label or study protocol specify?
  4. What monitoring will I receive during treatment, how long will observation continue, and whom should I contact after leaving?
  5. Is epinephrine immediately available, who can manage a severe reaction, and how would emergency transfer work?
  6. How are suspected reactions documented and reported, and will I receive the product name and batch details?

If the provider cannot resolve these questions, use them as criteria when comparing stem cell treatment providers in Japan. A vague safety promise is not a substitute for a product-specific answer.

Does Japanese registration prove allergy safety?

No. The Ministry of Health, Labour and Welfare publishes information on regenerative medicine providers and the required procedures. A listing is not evidence that a treatment is allergy-free or effective for your condition.Index The same distinction matters when considering broader stem cell therapy safety in Japan.

For treatment covered by Japan’s Act on the Safety of Regenerative Medicine, the framework includes provision-plan procedures, certified committee review, three risk-based classes, and reporting of suspected treatment-related disease, disability, death, or infection. Ask which provision plan and regulatory route apply to the proposed treatment.Plan

Plan submission and committee review are not the same as government marketing approval of a regenerative medical product. PMDA publishes product review and approval information through a separate track. Neither regulatory route replaces checking the specific product’s contraindications and emergency arrangements.0003

Before treatment in Japan, ask the clinic to clarify the proposed product, its ingredients, and the monitoring arrangements. This inquiry is not an emergency service.

Ask about treatment arrangements

Can stem cells treat allergies instead?

That is a different question from whether treatment can trigger a reaction. The FDA’s approved cell and gene therapy list contains no product indicated for hay fever, asthma, food allergy, or eczema.Approved cellular and gene therapy products A 2025 review of MSCs for allergic rhinitis describes mainly preclinical evidence and calls for phase I safety trials; it does not establish effectiveness in patients.40251675

Established allergy care includes trigger avoidance, appropriate medicines, and allergen immunotherapy when indicated. Do not replace prescribed allergy treatment with an experimental cell intervention.Allergy

What to take away

Stem cell treatment can cause an allergic reaction, but the risk depends on the exact product and surrounding procedure. The reported 3-in-54 Ryoncil discontinuations were infusion reactions, not a universal allergy rate; the 0.3% transplant figure covered several life-threatening complications, not just anaphylaxis. Check known ingredient allergies against the actual product, obtain a clear emergency plan, and seek immediate help for breathing difficulty, throat swelling, or collapse.